CD226 and breast cancer: However, high expression of CD226/TIGIT/CD96 had diverse effects on BC prognosis, CD226 expression on TILs and TIGIT expression on TC correlated with favorable prognosis, and CD226 and CD96 expression on TC and TIGIT expression on TILs may be related to unfavorable prognosis.